• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Medical Cannabis Policy Changes Brewing on the East Coast

Loren DeVito, PhD by Loren DeVito, PhD
November 28, 2018
in Industry News
Medical Cannabis Policy Changes Brewing on the  East Coast

Despite program expansions, cost remains a key barrier to access

The recent midterm elections brought some big wins for cannabis advocacy. In addition to Michigan adopting full legalization, both Missouri and Utah passed measures that provide access to medical cannabis. Many politicians who ran legalization platforms were elected, indicating that changes will continue sweeping the nation.

Just recently, dispensaries in Massachusetts finally opened for recreational purchases in a historic first for the East Coast. All eyes will be on the state as others in the region look to develop their models of cannabis policy and regulation. In fact, New York and New Jersey may be next to legalize recreational cannabis as the pendulum swings across the country.

READ ALSO

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

What Is Steam Distillation? Lessons From Food, Pharma and Supplements for Extraction Operators

While those living in these states have had access to medical cannabis, New Jersey has recently expanded its program to include additional conditions, such as migraines and chronic pain. The New York Health Department also issued recent guidance that recommends expanding New York’s program as well, in an effort to quell the opioid crisis and allow patients to use cannabis instead for pain management.

While making medical cannabis more available for prospective patients is critical in places where recreational cannabis remains illegal, patients may still face barriers to access due to cost. While each state’s program is handled differently, people first pay for a consultation with their physician to get certified. Then, they pay for their annual medical card, and, of course, for the products themselves. Depending on the condition, products alone may cost hundreds of dollars a month, with none of the cost covered by insurance.

Recent legislation introduced in New York looks to change that. Assemblyman Richard Gottfried and colleagues proposed a bill that would require public health care plans, including Medicaid, to cover medical cannabis to lower out-of-pocket costs. While this is great news, an obvious question remains – why haven’t insurance companies been covering medical cannab is costs if states have already approved these programs?

The Controlled Substances Act of 1970 categorized cannabis as a Schedule I drug – a compound with no currently accepted medical use and a high potential for abuse. Therefore, the FDA needs approve cannabis as an effective medicine before insurance companies will cover incurred costs.

Approval of this legislation would be a huge win for patients in New York and possibly send a signal to other states with similar programs. But, the issue of access does not fall on cost alone. One study discussed the finding that white Americans are the primary users of medical cannabis, as people from minority demographics may not seek out treatment due to stigma and fear of legal prosecution. [1] Additionally, socioeconomic status and physician attitudes can greatly influence both initiation of consultation and access to medicinal products.

As additional policy changes regarding medical cannabis use are implemented across states, legislators must also consider all aspects of access, including treatment and care, as part of their updated programs.

Reference

  1. Celina,V.I.,Asaolu, I.O., Ehiri, J.E., et al., “Structural Barriers in Access to Medical Marijuana in the USA—A Systematic Review Protocol”, Systematic Reviews, 2017, Volume 6, pg. 1-8.

(impact factor: 2.75; cited by: 1)

Related Posts

Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Botanical Extraction

What Is Steam Distillation? Lessons From Food, Pharma and Supplements for Extraction Operators

November 15, 2026
Equipment

Fractional Distillation vs Short Path Distillation: What Pharma and Food Plants Can Teach Extraction Operators

November 11, 2026
Botanical Extraction

Hydrosol vs Essential Oil: Which Product Stream Should Your Facility Be Built Around?

November 9, 2026
Business

What Should Investors Check Before Funding a Cannabis Extraction Operation?

November 6, 2026
Botanical Extraction

Which Compliance Mistakes Sink Extraction Startups, and How Do Mature Industries Avoid Them?

November 5, 2026
Next Post
Ardent Nova Decarboxylator

Ardent Nova Decarboxylator

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.